474 related articles for article (PubMed ID: 18029550)
21. New iron chelators in anthracycline-induced cardiotoxicity.
Kaiserová H; Simunek T; Sterba M; den Hartog GJ; Schröterová L; Popelová O; Gersl V; Kvasnicková E; Bast A
Cardiovasc Toxicol; 2007; 7(2):145-50. PubMed ID: 17652820
[TBL] [Abstract][Full Text] [Related]
22. Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system.
Bottone AE; de Beer EL; Voest EE
J Mol Cell Cardiol; 1997 Mar; 29(3):1001-8. PubMed ID: 9152861
[TBL] [Abstract][Full Text] [Related]
23. N-myc downstream regulated 1 gene and its place in the cellular machinery.
Kitowska A; Pawełczyk T
Acta Biochim Pol; 2010; 57(1):15-21. PubMed ID: 20300662
[TBL] [Abstract][Full Text] [Related]
24. Cu loading alters expression of non-IRE regulated, but not IRE regulated, Fe dependent proteins in HepG2 cells.
Fosset C; Danzeisen R; Gambling L; McGaw BA; McArdle HJ
J Inorg Biochem; 2009 May; 103(5):709-16. PubMed ID: 19232737
[TBL] [Abstract][Full Text] [Related]
25. The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species.
Wu X; Hasinoff BB
Anticancer Drugs; 2005 Jan; 16(1):93-9. PubMed ID: 15613911
[TBL] [Abstract][Full Text] [Related]
26. RGS19 converts iron deprivation stress into a growth-inhibitory signal.
Hwang J; Kim HS; Kang BS; Kim DH; Ryoo ZY; Choi SU; Lee S
Biochem Biophys Res Commun; 2015 Aug; 464(1):168-75. PubMed ID: 26116529
[TBL] [Abstract][Full Text] [Related]
27. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Richardson DR; Ponka P
J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
[TBL] [Abstract][Full Text] [Related]
28. Nickel decreases cellular iron level and converts cytosolic aconitase to iron-regulatory protein 1 in A549 cells.
Chen H; Davidson T; Singleton S; Garrick MD; Costa M
Toxicol Appl Pharmacol; 2005 Aug; 206(3):275-87. PubMed ID: 16039939
[TBL] [Abstract][Full Text] [Related]
29. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation.
Le NT; Richardson DR
Blood; 2004 Nov; 104(9):2967-75. PubMed ID: 15251988
[TBL] [Abstract][Full Text] [Related]
30. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
[TBL] [Abstract][Full Text] [Related]
31. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states.
Ellen TP; Ke Q; Zhang P; Costa M
Carcinogenesis; 2008 Jan; 29(1):2-8. PubMed ID: 17916902
[TBL] [Abstract][Full Text] [Related]
32. Regulation of gene expression in bovine blastocysts in response to oxygen and the iron chelator desferrioxamine.
Harvey AJ; Kind KL; Thompson JG
Biol Reprod; 2007 Jul; 77(1):93-101. PubMed ID: 17329595
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of transferrin receptor 1 transcription by a cell density response element.
Wang J; Chen G; Pantopoulos K
Biochem J; 2005 Dec; 392(Pt 2):383-8. PubMed ID: 16092918
[TBL] [Abstract][Full Text] [Related]
34. Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice.
Saadane N; Yue P; Alpert L; Mitmaker B; Kirby GM; Chalifour LE
Can J Physiol Pharmacol; 2001 Jun; 79(6):533-44. PubMed ID: 11430591
[TBL] [Abstract][Full Text] [Related]
35. Chemistry of dexrazoxane and analogues.
Hasinoff BB
Semin Oncol; 1998 Aug; 25(4 Suppl 10):3-9. PubMed ID: 9768817
[TBL] [Abstract][Full Text] [Related]
36. Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53.
Saletta F; Suryo Rahmanto Y; Noulsri E; Richardson DR
Mol Pharmacol; 2010 Mar; 77(3):443-58. PubMed ID: 20023006
[TBL] [Abstract][Full Text] [Related]
37. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.
Minotti G; Mancuso C; Frustaci A; Mordente A; Santini SA; Calafiore AM; Liberi G; Gentiloni N
J Clin Invest; 1996 Aug; 98(3):650-61. PubMed ID: 8698856
[TBL] [Abstract][Full Text] [Related]
38. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
Wallace DF; Summerville L; Subramaniam VN
Gastroenterology; 2007 Jan; 132(1):301-10. PubMed ID: 17241880
[TBL] [Abstract][Full Text] [Related]
39. The metastasis suppressor, N-myc downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells.
Sahni S; Bae DH; Lane DJ; Kovacevic Z; Kalinowski DS; Jansson PJ; Richardson DR
J Biol Chem; 2014 Apr; 289(14):9692-709. PubMed ID: 24532803
[TBL] [Abstract][Full Text] [Related]
40. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
Gharagozloo M; Khoshdel Z; Amirghofran Z
Eur J Pharmacol; 2008 Jul; 589(1-3):1-7. PubMed ID: 18619590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
